山东大学耳鼻喉眼学报 ›› 2015, Vol. 29 ›› Issue (5): 47-49.doi: 10.6040/j.issn.1673-3770.0.2015.150

• 论著 • 上一篇    下一篇

D-二聚体与鼻咽癌预后的关系

车娟1, 赵洪春1, 李金玲2, 王延飞1   

  1. 1. 滨州医学院附属医院耳鼻咽喉科, 山东 滨州 256603;
    2. 滨州医学院附属医院检验科, 山东 滨州 256603
  • 收稿日期:2015-04-09 修回日期:2015-07-09 出版日期:2015-10-16 发布日期:2015-10-16
  • 通讯作者: 王延飞,E-mail:cjbanana@163.com E-mail:cjbanana@163.com
  • 作者简介:车娟,E-mail:13375438181@163.com

The relationship between D-Dimer and nasopharyngeal carcinoma

CHE Juan1, ZHAO Hongchun1, LI Jinling2, WANG Yanfei1   

  1. 1. Department of Otolaryngology, the Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, China;
    2. Department of Laboratory Medicine, the Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, China
  • Received:2015-04-09 Revised:2015-07-09 Online:2015-10-16 Published:2015-10-16

PDF (PC)

880

被引次数

4

摘要： 目的 研究D-二聚体判断鼻咽癌预后的价值。方法 2009年1月至2012年12月前瞻性地比较了69例初诊鼻咽癌患者和69例健康个体就诊时的血浆D-二聚体水平,分析了鼻咽癌患者血浆D-二聚体水平与其临床分期的关系。采用受试者工作特征(ROC)曲线法和Kaplan-Meier法分析鼻咽癌患者D-二聚体与患者全因死亡率的关系。结果 鼻咽癌患者血浆D-二聚体水平显著高于健康个体。随着鼻咽癌分期的递进,患者血浆D-二聚体水平逐渐增高。D-二聚体预测患者死亡的ROC曲线下面积为0.72。二聚体高于0.55 mg/L的患者全因死亡的风险明显高于D-二聚体低于0.55 mg/L的患者。结论 D-二聚体是鼻咽癌的预后指标,其增高提示患者预后不良。

关键词: 预后, D-二聚体, 鼻咽癌

Abstract: Objective To investigate the prognostic value of plasma D-dimer for nasopharyngeal carcinoma. Method Sixty-nine nasopharyngeal carcinoma patients and their gender-and age-matched healthy individuals were prospectively enrolled, and their plasma D-Dimer on admission were compared. The association between plasma D-Dimer and clinical stage of nasopharyngeal carcinoma was analyzed. The prognostic value of D-dimer for all-cause mortality was estimated by receiver operating characteristic (ROC) curves and Kaplan-Meier approach. Results Compared with healthy individuals, nasopharyngeal patients had significantly higher plasma D-dimer. Plasma D-Dimer increased as the advance of clinical stage of nasopharyngeal carcinoma. The area under ROC curve of plasma D-Dimer for all-cause mortality was 0.72. Patients with increased D-Dimer (more than 0.55 mg/L) have higher risk of death than the patients with normal D-Dimer (less than 0.55 mg/L). Conclusion D-Dimer is a useful prognostic factor for nasopharyngeal carcinoma. Increased D-Dimer is associated with poor prognosis.

Key words: D-Dimer, Prognosis, Nasopharyngeal carcinoma

中图分类号: 

  • R766.3
[1] 邹丽芳, 朱琦, 程毅敏, 等. 血液系统恶性肿瘤患者止凝血功能的研究[J]. 血栓与止血学, 2013, 19(6):257-260. ZOU Lifang, ZHU Qi, CHENG Yimin, et al. The study of heamostatic function in patients with hematological malignancy[J]. Chin J Thrombosis Hemostasis, 2013, 19(6):257-260.
[2] 许小毛, 王辰. 肿瘤与静脉血栓栓塞症[J]. 中国实用内科杂志, 2013, 33(5):344-347. XU Xiaomao, WANG Chen. Cancer and venous thromboembolism[J]. Chin J Prac Inter Med, 2013, 33(5):344-347.
[3] Olson J D, Cunningham M T, Higgins R A, et al. D-dimer: simple test, tough problems[J]. Arch Pathol Lab Med, 2013, 137(8):1030-1038.
[4] Tripodi A. D-dimer testing in laboratory practice[J]. Clin Chem, 2011, 57(9):1256-1262.
[5] Zhou Y X, Yang Z M, Feng J, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis[J]. Tumour Biol, 2013, 34(6):3701-3704.
[6] Liu L, Zhang X, Yan B, et al. Elevated plasma d-dimer levels correlate with long term survival of gastric cancer patients[J]. PLoS One, 2014, 9(3):e90547.
[7] 张弘, 刘陶文, 莫碧媛, 等. 鼻咽癌患者血浆D-二聚体水平测定的临床价值[J]. 华夏医学, 2009, 22(1):55-56. ZHANG Hong, LIU Taowen, MO Biyuan, et al. Clinical value of D-Dimer in nasopharyngeal carcinoma[J]. Acta Med Sinica, 2009, 22(1):55-56.
[8] 胡志德, 王璐璐, 赫慧楠. 5种恶性肿瘤患者血浆D二聚体阳性检出率比较[J]. 血栓与止血学, 2006, 12(6):2. HU Zhide, WANG Lulu, HE Huinan. The positive rate of plasma d-dimer in five type patients with malignant tumor[J]. Chin J Thrombosis Hemostasis, 2006, 12(6):2.
[9] Coussens L M, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917):860-867.
[10] Cugno M. Inflammation, coagulation, vascular permeability and thrombosis[J]. Curr Vasc Pharmacol, 2012, 10(5):631.
[1] 林小雪,林葆睿,李佩珊,卢标清. 电子鼻咽镜联合窄带成像技术在鼻咽癌中医辨证中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 40-46.
[2] 刘佳珲,田汝宪,李玉梅,宋西成. 构建铜死亡相关lncRNA模型评估头颈鳞状细胞癌预后[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 49-64.
[3] 缪红利,张妍春,郝琳娜,唐乐,何英楠. 活动性眼弓形虫病临床特征及预后分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 82-89.
[4] 彭中华,陈竹,袁洛花,余绍兰,马玉玲. 原发性鼻腔高级别非肠型腺癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 95-98.
[5] 李赞,卢奇,申卫东,侯昭晖,吴南. 坏死性外耳道炎临床诊治18例[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 17-22.
[6] 刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137.
[7] 王盛,李银丹,杨金姬. microRNA在鼻咽癌中的作用及其研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 125-131.
[8] 邱前辉,肖旭平,杨钦泰,叶菁,邓泽义,王德生,谭国林,蒋卫红,卢永田,唐隽,石照辉,邓晓聪,刘遗斌,王跃武,段传志,杜德坤,白小欣,陈文伙,莫立根,蔡楚伟,曾鹏,何旭英,杨一梅,赵洲洋,陈健龙,赵充,林志雄,李先明,李曙平,陈冬平,陈勇,黄莹,陈春燕,韩非,黄理金,瞿申红. 鼻咽癌治疗后并发颈动脉爆裂综合征的临床处理专家共识[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 1-18.
[9] 王思权,朱洪申,张晓斌,赵洲洋,马跃,杨一梅,黄理金. 放射治疗后鼻咽癌患者单侧颈内动脉栓塞术后脑卒中及颅神经麻痹的相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 19-25.
[10] 黄巧,任毅,侯涛,廖行伟,朱子昂,詹晓琳,刘盈,尹时华. 鼻咽癌组织中EphB2表达及与临床病理特征的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 26-30.
[11] 孙春晓,王文晴,岳田,刘济生. 高低累积顺铂剂量同步放化疗治疗鼻咽癌的疗效分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 31-41.
[12] 徐飞,朱光熹,王可心. 基于决策树算法构建鼻咽癌患者放疗后发生放射性口腔黏膜炎风险的预测模型[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 42-48.
[13] 王再兴,唐志元,李定波,石照辉,曾宪海,张秋航. 鼻咽癌放疗后肿瘤复发及颅底骨坏死引起颈内动脉破裂的治疗方案[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 49-58.
[14] 孙芳,谢楚波,邱前辉. 营养指标对鼻咽癌放射性颅底坏死患者创面修复影响的回顾性分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 59-68.
[15] 朱瑞楷,吴家荣,孙芳,谢楚波,邱前辉. 基于计算机断层扫描血管造影术评估鼻咽癌放疗后引起颈内动脉狭窄状况及其影响因素的研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 77-84.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发